Experience

Forian Inc. (FORA: NASDAQ)

• Vice President, Corporate Development

  • Jan 2021 - Present

  Technology, analytics and data science provider to optimize operational, financial and clinical performance for the healthcare industry • Identify and pursue investment and other opportunities, assist in setting strategic direction to maximize shareholder value and monitor and enhance the operating performance of Forian’s businesses. Technology, analytics and data science provider to optimize operational, financial and clinical performance for the healthcare industry • Identify and pursue investment and other opportunities, assist in setting strategic direction to maximize shareholder value and monitor and enhance the operating performance of Forian’s businesses.



Phreesia (PHR: NYSE)

• United States
• IT Services and IT Consulting

• Vice President, Finance & Strategy

  • Jan 2019 - Dec 2020

  Leading SaaS-based patient intake, engagement and payments platform for healthcare providers with over 1,700 clients, $140 million of revenue and 800 employees (growing 20%+ per year). • Capital Markets - Managed the $192 million IPO at a $670M valuation (upsized, priced above the range). Ran tight 5-month process from kickoff to close, hitting every major deadline. Quarterbacked the $202 million secondary equity offering (45% premium to IPO price 5 months later). • FP&A - Led the integrated planning process (semi-annual budgeting, monthly forecasting, multi-year strategic plans). Improved business insights and drove cross functional alignment and accountability by developing and monitoring key financial and operational metrics (product/client unit economics, retention, expansion and usage). Managed and coached FP&A team and helped build out the finance organization to transition to a publicly traded company. • Operational Finance - Negotiated and evaluated key business supplier relationships (payments, benefits eligibility) to optimize costs and drive operating leverage. Show less



Independent Consultant / Advisor

• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Financial Planning, Corporate Strategy & Business Development Consultant / Advisor

  • Nov 2017 - Dec 2018

  • Advised owner/operator of a private health services company on sale/capital raise process. Served as interim CFO in preparing company business and financial materials • Advised owner/operator of a private health services company on sale/capital raise process. Served as interim CFO in preparing company business and financial materials



WebMD (WBMD: NASDAQ)

• Senior Vice President & Head of Corporate & Business Development

  • May 2014 - Oct 2017

  Largest provider of online health information services for consumers and physicians and cloud-based health management platform for employers and health plans. 1,700 employees, $700 million of revenue, $156 million of free cash flow. Member of senior leadership team and led growth and capital allocation initiatives. Held multiple corporate strategy and business development roles of increasing responsibility since 2001. • Liquidity Event - Led the $2.8 billion sale to KKR/Internet Brands (all-time high share price; 30% premium)• Capital Markets - Raised $2.2 billion via 7 convertible debt & preferred issuances to fund acquisitions and product development.• Acquisitions - Acquired 4 companies for $629M that transformed Emdeon (now Change Healthcare) from a commodity healthcare claims clearinghouse into a leading provider of revenue cycle and payment solutions. Revenue and cash flow grew 8% and 20% organically after years of flat performance. • Carveout Divestitures - Streamlined portfolio of diverse operating businesses to focus on higher growth/margin digital marketing business through the sale of 4 subsidiaries for $2.8 billion in cash to corporate and private equity buyers.• Reverse Merger - Unlocked value by structuring the $1.6B reverse merger of WebMD and HLTH that eliminated the liquidity discount for HLTH’s ownership of WebMD and redundancies of two public companies.• Revenue Generating Commercial Relationships - Partnered with Sanford Health, a large health system, to develop a new online resource for children and parents to combat childhood obesity. Structured a performance-based digital marketing relationship with Amarin, a mid-sized biopharma, for commercial launch of its new cardiology drug.• Share Repurchases - Executed 11 self-tender share buybacks for $5.4B (1 for 45% of the equity during the financial crisis). Avg. cost basis was $27.75/share compared to the $66.50 acquisition price resulting in a $7.5B profit and a 2.4x ROI. Show less

• Vice President, Corporate & Business Development

  • Mar 2004 - Apr 2014

• Senior Director, Corporate & Business Development

  • Mar 2003 - Feb 2004

• Director, Corporate & Business Development

  • May 2002 - Feb 2003


WebMD
• Technology, Information and Internet
• 700 & Above Employee
• Summer Associate, Corporate & Business Development

  • May 2001 - Aug 2001


Domain Associates

• United States
• Venture Capital and Private Equity Principals
• 1 - 100 Employee

• Investment Associate, Healthcare Venture Capital

  • Dec 1997 - May 2000

  Founded in 1985 as one of the first life sciences venture capital firms with $2.8 billion in assets raised Identified, evaluated, structured and monitored new and follow-on life sciences and medical technology investments across all stages from seed/company incubation to growth public equity. 1st non-MBA investment professional hired. • Growth Public Equity - Devised oncology investment thesis, structured a $23M PIPE (firm’s largest at time) for a 10% stake in U.S. Bioscience, a small cap public cancer drug company, during biotech bear market. Partnered with CEO to evaluate 30 potential acquisitions to build product pipeline. Realized a 2.4x ROI upon sale of company in less than a year. • Company Incubation / Formation - Participated in formation of Molecular Staging, a spin-out genomics company from Yale University. Involved with technology transfer, $10M initial financing, hiring team, securing facilities, equipment financing. Attended Board meetings and advised company on acquisition. Show less



PaineWebber (Acquired by UBS)

• Financial Analyst, Healthcare Investment Banking

  • Jul 1995 - Nov 1997

  Advised and executed $800M of financing and merger transactions for emerging life sciences, medical technology and healthcare service clients. Offered 3rd year analyst position Advised and executed $800M of financing and merger transactions for emerging life sciences, medical technology and healthcare service clients. Offered 3rd year analyst position